Negin Fraidouni Selected Research

Tetraethylammonium (Tetraethylammonium Bromide)

4/2016	Pretreatment with potassium channel blockers of 4-aminopyridine and tetraethylammonium attenuates behavioural symptoms of Parkinsonism induced by intrastriatal injection of 6-hydroxydopamine; the role of lipid peroxidation.
9/2011	Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Negin Fraidouni Research Topics

Disease

5	Parkinsonian Disorders (Parkinsonism) 05/2017 - 09/2011
3	Parkinson Disease (Parkinson's Disease) 09/2014 - 09/2011
2	Nervous System Diseases (Neurological Disorders) 09/2014 - 09/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2017
1	Hyperhomocysteinemia 08/2012
1	Dyskinesias (Dyskinesia) 09/2011
1	Multiple Sclerosis 09/2011
1	Ataxia (Dyssynergia) 09/2011
1	Alzheimer Disease (Alzheimer's Disease) 09/2011

Drug/Important Bio-Agent (IBA)

5	Oxidopamine (6 Hydroxydopamine)IBA 05/2017 - 09/2011
2	Neuroprotective AgentsIBA 05/2017 - 04/2016
2	Vitamin B Complex (B Vitamins)IBA 05/2017 - 08/2012
2	TeaIBA 04/2016 - 09/2011
2	4-Aminopyridine (4 Aminopyridine)FDA Link 04/2016 - 09/2011
2	Tetraethylammonium (Tetraethylammonium Bromide)IBA 04/2016 - 09/2011
2	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 04/2016 - 09/2011
2	HomocysteineIBA 09/2014 - 08/2012
1	KATP ChannelsIBA 05/2017
1	Glyburide (Glibenclamide)FDA LinkGeneric 05/2017
1	PotassiumIBA 05/2017
1	Adenosine Triphosphate (ATP)IBA 05/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2012
1	Levodopa (L Dopa)FDA LinkGeneric 09/2011